• Hakkımızda
  • İletişim/Künye
  • Dergimize Abone Olun
  • E-Dergi
MEDİKAL TEKNİK
Eryigit
  • Anasayfa
  • Güncel
  • Medikal Ekipman
  • Sağlık
  • İlaç
  • Röportaj
  • Atama
  • Makale
  • |ENGLISH|
  • E-Dergi
No Result
View All Result
  • Anasayfa
  • Güncel
  • Medikal Ekipman
  • Sağlık
  • İlaç
  • Röportaj
  • Atama
  • Makale
  • |ENGLISH|
  • E-Dergi
No Result
View All Result
MEDİKAL TEKNİK
No Result
View All Result

Syensqo introduces medical-grade Amodel® PPA for single-use, high-temperature medical devices

A new medical-grade Amodel® PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies

22 Eylül 2025
0
Syensqo introduces medical-grade Amodel® PPA for single-use, high-temperature medical devices

Syensqo today launched a new medical-grade Amodel® polyphthalamide (PPA). The glass-filled polymer is engineered for advanced single-use medical devices, delivering exceptional heat resistance, robust electrical properties, and key biocompatibility requirements for limited contact duration medical applications.

Amodel® PPA features a high melting point above 300 °C and maintains mechanical strength at temperatures up to 280 °C. These properties make it ideal for demanding manufacturing processes such as surface-mount technology (SMT) assembly, infrared (IR) reflow, and metal overmolding. The material is particularly well-suited for electrosurgical instruments and electronic device assemblies, where complex, injection-molded geometries offer advantages over alternative materials.

“For decades, brands like Radel® and Udel® have helped advance medical technologies. With medical-grade Amodel® PPA, we’re extending that legacy, giving customers a new option for devices that must withstand modern assembly processes,” said Natalie Dragunat, Global Marketing Manager, Healthcare at Syensqo.

Amodel® PPA medical-grade is available for sampling, with commercial availability expected in 2026.

Amodel®, Radel® and Udel® are registered trademarks of Syensqo.

Tags: #technologyAmodel® polyphthalamideAmodel® PPAGlobal Marketing ManagerHealthcare at Syensqomedical applicationsNatalie DragunatPPARadel®Udel®
Previous Post

Nobel İlaç’ın Yeni Genel Müdürü Dr. Oğuz Mülazımoğlu oldu

Next Post

Mikroplara karşı yeni nesil koruma

editor

Next Post
Mikroplara karşı yeni nesil koruma

Mikroplara karşı yeni nesil koruma

Bir yanıt yazın Yanıtı iptal et

E-posta adresiniz yayınlanmayacak. Gerekli alanlar * ile işaretlenmişlerdir

  • Anasayfa
  • Güncel
  • Medikal Ekipman
  • Sağlık
  • İlaç
  • Röportaj
  • Atama
  • Makale
  • |ENGLISH|
  • E-Dergi

© 2024 Medikal Teknik Dergisi.

No Result
View All Result
  • Anasayfa
  • Güncel
  • Medikal Ekipman
  • Sağlık
  • İlaç
  • Röportaj
  • Atama
  • Makale
  • |ENGLISH|
  • E-Dergi

© 2024 Medikal Teknik Dergisi.